We are live on
!
Find out more
VanEck Pharmaceutical ETF
PPH
PPH
146 hedge funds and large institutions have $806M invested in VanEck Pharmaceutical ETF in 2025 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 41 increasing their positions, 45 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
105% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 19
42% more call options, than puts
Call options by funds: $7.55M | Put options by funds: $5.33M
15% more funds holding
Funds holding: 127 → 146 (+19)
13% more capital invested
Capital invested by funds: $713M → $806M (+$93.1M)
9% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 45
45.98% less ownership
Funds ownership: 114.6% → 68.62% (-46%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
146
Holders Change
+19
Holders Change %
+14.96%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
39
Increased
41
Reduced
45
Closed
19
Calls
$7.55M
Puts
$5.33M
Net Calls
+$2.22M
Net Calls Change
+$52.4M
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$105M |
| 2 |
Morgan Stanley
New York
|
-$36.8M |
| 3 |
JP Morgan Chase
New York
|
-$24.7M |
| 4 |
RAM
Revere Asset Management
Dallas,
Texas
|
-$15.6M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$6.85M |
